|
|
|
Volumn 25, Issue 4, 1998, Pages 492-502
|
|
Lymphomas in the immunocompromised patient
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASPARAGINASE;
AZACITIDINE;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DIDANOSINE;
DOXORUBICIN;
ETOPOSIDE;
FOLINATE CALCIUM;
FOSCARNET;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
INTERLEUKIN 2;
LOMUSTINE;
METHOTREXATE;
MITOXANTRONE;
PREDNIMUSTINE;
PREDNISONE;
PROCARBAZINE;
VINCRISTINE;
VINDESINE;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BONE MARROW TOXICITY;
BONE MARROW TRANSPLANTATION;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DOSE RESPONSE;
HUMAN;
HUMAN HERPESVIRUS 8;
IMMUNOPATHOGENESIS;
INTRATHECAL DRUG ADMINISTRATION;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISEASE;
ONCOGENE;
ORAL DRUG ADMINISTRATION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
TUMOR SUPPRESSOR GENE;
VIRUS CARCINOGENESIS;
BONE MARROW TRANSPLANTATION;
HUMANS;
IMMUNOCOMPROMISED HOST;
LYMPHOMA;
LYMPHOMA, AIDS-RELATED;
ORGAN TRANSPLANTATION;
TRANSPLANTATION IMMUNOLOGY;
|
|
EID: 0031928564
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (57)
|
|
References (103)
|
